XML 49 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Equity Method Investment in Equity Investee - Schedule of Gain on Deconsolidation (Details)
$ in Thousands, ¥ in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 26, 2022
USD ($)
Jan. 26, 2022
CNY (¥)
Dec. 24, 2021
USD ($)
Dec. 24, 2021
CNY (¥)
Dec. 31, 2021
USD ($)
Dec. 31, 2021
CNY (¥)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Dec. 01, 2021
USD ($)
Schedule of Equity Method Investments [Line Items]                      
Cash received for sales of shares in the JV Company                 $ 26,347 $ 0  
Gain on deconsolidation of the JV Company             $ 0 $ 0 399,093 0  
Share-based Payment Arrangement, Expense             (8,273) (3,825) (21,454) (9,925)  
Loss on changes on equity interest of the JV Company, net                 (3,140) 0  
Gain (loss) on changes of equity interest in the JV Company, net             $ 4,501 $ 0 (3,140) $ 0  
Joint Venture                      
Schedule of Equity Method Investments [Line Items]                      
Cash received for sales of shares in the JV Company         $ 16,924            
Fair value of retained equity method investment         393,124            
Carrying amount of non-controlling interest         143,889            
Cumulative translation adjustment removal         1,793            
Carrying amount of net assets of the JV Company at December 1, 2021                     $ (156,637)
Gain on deconsolidation of the JV Company         399,093            
Share-based Payment Arrangement, Expense                 (8,116)    
Loss on changes on equity interest of the JV Company, net                 $ (3,140)    
Joint Venture | Third Party Investor                      
Schedule of Equity Method Investments [Line Items]                      
Cash received for sales of shares in the JV Company $ 80,000 ¥ 509.0 $ 9,400 ¥ 60.0 $ 16,900 ¥ 108.0          
Gain on deconsolidation of the JV Company $ 4,501   $ 475